IRIS
DICHIARA, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.309
EU - Europa 1.233
AS - Asia 447
AF - Africa 157
SA - Sud America 77
OC - Oceania 6
Totale 3.229
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.285
IT - Italia 638
SG - Singapore 275
DE - Germania 213
IE - Irlanda 133
CN - Cina 132
CI - Costa d'Avorio 120
FI - Finlandia 104
BR - Brasile 72
RU - Federazione Russa 37
SN - Senegal 33
CA - Canada 21
ES - Italia 18
UA - Ucraina 18
FR - Francia 13
GB - Regno Unito 12
CZ - Repubblica Ceca 9
JP - Giappone 9
NL - Olanda 9
SE - Svezia 7
VN - Vietnam 7
BE - Belgio 5
TR - Turchia 5
AU - Australia 4
GR - Grecia 4
IN - India 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
CH - Svizzera 3
HU - Ungheria 3
AR - Argentina 2
EC - Ecuador 2
MX - Messico 2
NZ - Nuova Zelanda 2
PL - Polonia 2
ZA - Sudafrica 2
BD - Bangladesh 1
CL - Cile 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HK - Hong Kong 1
IL - Israele 1
IQ - Iraq 1
KZ - Kazakistan 1
LB - Libano 1
MA - Marocco 1
ME - Montenegro 1
NP - Nepal 1
PS - Palestinian Territory 1
RO - Romania 1
Totale 3.229
Salva come PNG Salva come JPEG
Città #
Chandler 295
Santa Clara 272
Munich 182
Singapore 160
Catania 145
Chicago 138
Dublin 132
Abidjan 120
Helsinki 79
Civitanova Marche 60
Ashburn 58
Boardman 54
Naples 38
Cambridge 33
Dakar 33
Lawrence 33
Andover 31
Nanjing 28
Bremen 21
Des Moines 21
Milan 17
Toronto 17
Council Bluffs 16
Jacksonville 16
Palermo 14
Rome 14
The Dalles 13
Houston 12
Jyväskylä 12
Messina 11
Centro 10
Madrid 10
Tokyo 9
Brno 8
Sala Baganza 8
Cagliari 7
Florence 7
Hebei 7
Hefei 7
Pozzallo 7
Shenyang 7
Wilmington 7
Changsha 6
Lappeenranta 6
Los Angeles 6
Moscow 6
Nanchang 6
Phoenix 6
Saint Petersburg 6
Scafati 6
Terrassa 6
Brussels 5
Civitavecchia 5
Dong Ket 5
Groningen 5
Raffadali 5
São Paulo 5
Aci Catena 4
Bari 4
Beijing 4
Belo Horizonte 4
Curitiba 4
Guangzhou 4
Jiaxing 4
Marseille 4
Mascalucia 4
Pozzo Di Gotto 4
San Francisco 4
San Giovanni la Punta 4
Santa Maria di Licodia 4
Augusta 3
Bologna 3
Budapest 3
Castelvetrano 3
Dearborn 3
Gravina di Catania 3
Kunming 3
Misterbianco 3
New Haven 3
New York 3
Ottawa 3
Porto San Giorgio 3
Randazzo 3
Redwood City 3
Reggio Calabria 3
Rimini 3
Salerno 3
Tashkent 3
Tianjin 3
Villamagna 3
Washington 3
Zhengzhou 3
Amsterdam 2
Chioggia 2
Como 2
Desio 2
Dnipro 2
Esslingen am Neckar 2
Foggia 2
Froges 2
Totale 2.387
Salva come PNG Salva come JPEG
Nome #
Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors 215
Composti inorganici [Cap. 6] 200
Design, synthesis, and pharmacological evaluation of NO donor-sigma receptors hybrids for the treatment of cancer 123
Exploiting the Power of Stereochemistry in Drug Action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as Potent Sigma-1 Receptor Antagonist 107
Combination of heme oxygenase-1 inhibition and sigma receptor modulation for anticancer activity 105
Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis 100
Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists 95
Sigma-2 receptor ligands QSAR model dataset 91
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma 89
Development of Sigma Receptors Nitric Oxide Photodonor Ligands with Antiproliferative Activity 86
(+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] Derivatives as Potent and Selective Sigma Receptor Ligands: Stereochemistry and Pharmacological Properties 84
Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors 82
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 82
La modellistica molecolare applicata ai recettori Sigma-1 e Sigma-2: un excursus 81
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review 80
Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands 80
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation 78
Novel Sigma-1 receptor antagonists: From opioids to small molecules: What is new? 75
CNS permeability parameters determination through a statistical analysis driven approach 74
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 70
Tumor Targeting Sigma Receptor Ligands: Development of New Molecular Hybrids as Anticancer Therapeutics 69
New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders 69
Cytotoxicity Profiles and Neuroprotective Properties of the Novel Ifenprodil Analogues as Sigma Ligands 66
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands 66
Morphing of ibogaine: A successful attempt into the search for sigma-2 receptor ligands 66
Development of novel H2S-donor sigma receptor hybrids for the management of pain. 66
Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis 65
Novel Sigma Receptors Ligands-Nitric Oxide Photodonor: Molecular Hybrids for Double-Targeted Antiproliferative Effect 64
Development of NO-releasing sigma receptor hybrids as anticancer agents 64
Design, Synthesis, and Cytotoxic Assessment of New Haloperidol Analogues as Potential Anticancer Compounds Targeting Sigma Receptors 63
Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation 63
Targeting the hydrophobic heme oxygenase-1 western region for the identification of novel and selective azole-based inhibitors. 62
Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activity 54
Novel N-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics in Inflammatory Pain 53
Repurposing of human kinase inhibitors in neglected protozoan diseases 53
Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents 53
New Insights into the Opioid Analgesic Profile of cis-(-)-N-Normetazocine-derived Ligands 48
Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents 48
Synthesis, Computational Insights, and Evaluation of Novel Sigma Receptors Ligands 44
H2S releasing molecules in pharmaceutical development 41
Exploring Structural Requirements for Sigma-1 Receptor Linear Ligands: Experimental and Computational Approaches 41
Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H3 and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties 40
Discovery and computational studies of piperidine/piperazine-based compounds endowed with sigma receptor affinity 37
Correction to Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 36
Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic Activity 33
Sintesi e valutazione preclinica di ligandi per i recettori sigma utili per il trattamento dei tumori e per la gestione del dolore 26
Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain 25
Development of selective sigma-1 receptor ligands with antiallodynic activity: A focus on piperidine and piperazine scaffolds 6
Design and Synthesis of Tetrahydropyrrolo[3,4‐c]Pyrazole Sigma‐1 Receptor Ligands 3
Totale 3.421
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.752
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.752
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202021 0 0 0 0 0 0 0 0 0 0 11 10
2020/2021145 5 1 14 34 44 2 15 1 5 0 10 14
2021/2022320 19 39 26 15 47 4 42 8 23 16 4 77
2022/2023745 69 66 15 107 49 116 8 123 143 9 34 6
2023/2024435 21 58 17 19 37 133 21 19 1 8 70 31
2024/20251.463 55 214 56 125 221 200 201 105 163 82 41 0
Totale 3.421